Cargando…
Low expression of the K280N TNNT2 mutation is sufficient to increase basal myofilament activation in human hypertrophy cardiomyopathy
BACKGROUND: Hypertrophic cardiomyopathy (HCM) is an autosomal dominant genetic disorder with patients typically showing heterozygous inheritance of a pathogenic variant in a gene encoding a contractile protein. Here, we study the contractile effects of a rare homozygous mutation using explanted tiss...
Autores principales: | Sequeira, Vasco, Wang, Lili, Wijnker, Paul J.M., Kim, Kyungsoo, Pinto, Jose R., dos Remedios, Cris, Redwood, Charles, Knollmann, Bjorn C., van der Velden, Jolanda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier, Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10160007/ https://www.ncbi.nlm.nih.gov/pubmed/37159677 http://dx.doi.org/10.1016/j.jmccpl.2022.100007 |
Ejemplares similares
-
Protein phosphatase 2A affects myofilament contractility in non-failing but not in failing human myocardium
por: Wijnker, Paul J. M., et al.
Publicado: (2011) -
Diastolic myofilament dysfunction in the failing human heart
por: van der Velden, Jolanda
Publicado: (2011) -
The homozygous K280N troponin T mutation alters cross-bridge kinetics and energetics in human HCM
por: Piroddi, Nicoletta, et al.
Publicado: (2019) -
Increased Myocardial Oxygen Consumption Precedes Contractile Dysfunction in Hypertrophic Cardiomyopathy Caused by Pathogenic TNNT2 Gene Variants
por: Parbhudayal, Rahana Y., et al.
Publicado: (2020) -
Dystrophic cardiomyopathy: role of the cardiac myofilaments
por: George, Thomas G., et al.
Publicado: (2023)